West Pharmaceutical Services (WST) Treasury Shares (2009 - 2026)

West Pharmaceutical Services' Treasury Shares history runs 18 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Treasury Shares rose 18.56% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 18.56% YoY), while the FY2025 annual figure was $1.1 billion, up 5.21% from the prior year.
• Treasury Shares came in at $1.4 billion for Q1 2026 at West Pharmaceutical Services, up from $1.1 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.4 million in Q2 2025 to a low of $77329.0 in Q3 2023.
• A 5-year average of $1.5 million and a median of $1.2 million in 2026 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 123.51% in 2024 and increased 5.21% in 2025, its largest moves.
• West Pharmaceutical Services' Treasury Shares stood at $370.9 million in 2022, then jumped by 71.91% to $637.6 million in 2023, then soared by 65.79% to $1.1 billion in 2024, then climbed by 5.21% to $1.1 billion in 2025, then gained by 24.0% to $1.4 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.4 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison